Table 2.
Condition | Agent | Target Antigen | Phage | Ref. |
---|---|---|---|---|
Viral infections | SARS-CoV-2 | S protein, NP | Lambda, AP205, QβBxb1, Bxb2 | [34,39,40,47,67,86,92] |
Influenza A virus | 3M2e | T4 | [38] | |
Dengue virus | NS1 | Qβ | [93] | |
Foot-and-mouth disease | VP1 | MS2, T7 | [36,48] | |
Zika virus | E protein | Qβ | [36] | |
Bacterial infections | Chlamydia trachomatis | CT584, MOMP | Qβ, MS2 | [49,94] |
Escherichia coli | STh | AP205 | [95] | |
Vibrio Cholera | OSP | Qβ | [96] | |
Bordetella pertussis | Pentasaccharide | Qβ | [97] | |
Parasite infections | Rhipicephalus microplus | Sbm746 | M13 | [41] |
Fasciola hepatic | Cathepsin | M13KE | [42,98] | |
Plasmodium falciparum | Pfs47 | AP205 | [51] | |
Yeast infections | Candida albicans | Fba1 | M13 | [99] |
Cancer | Breast cancer | HER2, xCT | Lambda, M13, MS2 | [35,43,100,101] |
Leukemia | ASPH | SNS-301 | [15] | |
General | GD2 | Qβ | [102] | |
Metastasis and solid tumor | MUC1 | Qβ | [103] | |
Melanoma | Neoantigens | T7 | [37] | |
Other conditions | Tauopathies | Tau | Qβ | [104] |
Hypertension | CaV1.2 | Qβ | [46] | |
Allergic rhinitis | H4R | M13 | [105] | |
Cardiovascular diseases | ApoB, PCSK9, and CETP | Qβ | [66] | |
Fertility control | Gonadotropins | f8 | [45] |